Hepatic resection of non-colorectal or non-neuroendocrine liver metastases is a useful therapy strategy to improve survival

Resection of liver metastases from colorectal cancer is the gold standard treatment option with low peri-operative mortality and a 5-year survival of ˜40%. However, there is an ongoing debate on benefit and long-term survival of hepatic resection of non-colorectal (NCRC) and non-neuroendocrine (NNEC) liver metastases. Design: Therefore, in the present study we investigated the potential survival benefit of patients undergoing resection of NCRC or NNEC liver metastases, enabling even repeated resections in recurrent disease. Data from a prospectively maintained database of patients undergoing hepatic resection fo…